Holdings of ProShares Ultra Nasdaq Biotechnology
ProShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 73.7M $ including 46.4M $ in equities, 63.0 %
- Positions
- 253 in 18 countries
- Top ten
- 25.7 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 25,542 | 3.4M $ | 4.66 % |
| 2 | Vertex Pharmaceuticals Inc | 7,657 | 3.4M $ | 4.65 % |
| 3 | Amgen Inc | 9,803 | 3.3M $ | 4.48 % |
| 4 | Regeneron Pharmaceuticals Inc | 3,840 | 2.4M $ | 3.21 % |
| 5 | ALNYLAM PHARMACEUTICALS INC | 4,904 | 1.5M $ | 2.01 % |
| 6 | REVOLUTION MEDICINES INC | 7,326 | 1.2M $ | 1.57 % |
| 7 | Biogen Inc | 5,425 | 1.1M $ | 1.44 % |
| 8 | Illumina Inc | 5,653 | 921.2K $ | 1.25 % |
| 9 | United Therapeutics Corp | 1,620 | 902K $ | 1.22 % |
| 10 | ROYALTY PHARMA PLC | 15,837 | 883.1K $ | 1.20 % |
| 11 | Argenx SE | 1,050 | 877.8K $ | 1.19 % |
| 12 | Insmed Inc | 7,968 | 851.9K $ | 1.16 % |
| 13 | Roivant Sciences Ltd | 26,460 | 793.5K $ | 1.08 % |
| 14 | Incyte Corp | 7,359 | 711.9K $ | 0.97 % |
| 15 | VIATRIS INC | 42,565 | 692.1K $ | 0.94 % |
| 16 | MODERNA INC | 14,600 | 689K $ | 0.94 % |
| 17 | GUARDANT HEALTH INC | 4,850 | 629K $ | 0.85 % |
| 18 | Neurocrine Biosciences Inc | 3,712 | 587.6K $ | 0.80 % |
| 19 | JAZZ PHARMACEUTICALS PLC | 2,275 | 538K $ | 0.73 % |
| 20 | Ascendis Pharma A/S | 2,276 | 510.1K $ | 0.69 % |
| 21 | Summit Therapeutics Inc | 28,664 | 502.8K $ | 0.68 % |
| 22 | Exelixis Inc | 9,600 | 484.6K $ | 0.66 % |
| 23 | Bridgebio Pharma Inc | 7,167 | 474.9K $ | 0.64 % |
| 24 | Medpace Holdings Inc | 1,051 | 469.9K $ | 0.64 % |
| 25 | IONIS PHARMACEUTICALS INC | 6,109 | 467.3K $ | 0.63 % |
| 26 | Axsome Therapeutics Inc | 1,890 | 443.2K $ | 0.60 % |
| 27 | Madrigal Pharmaceuticals Inc | 847 | 421.2K $ | 0.57 % |
| 28 | BioMarin Pharmaceutical Inc | 7,110 | 407.3K $ | 0.55 % |
| 29 | BioNTech SE | 4,213 | 404.2K $ | 0.55 % |
| 30 | Arrowhead Pharmaceuticals Inc | 5,178 | 403.4K $ | 0.55 % |
| 31 | SANOFI SA | 9,047 | 395.1K $ | 0.54 % |
| 32 | Praxis Precision Medicines Inc | 1,029 | 360.1K $ | 0.49 % |
| 33 | CYTOKINETICS INC | 4,553 | 349.5K $ | 0.47 % |
| 34 | BEONE MEDICINES LTD | 1,181 | 340K $ | 0.46 % |
| 35 | Krystal Biotech Inc | 1,080 | 333.8K $ | 0.45 % |
| 36 | Tempus AI Inc | 6,424 | 324.2K $ | 0.44 % |
| 37 | ABIVAX SA | 2,271 | 301.2K $ | 0.41 % |
| 38 | Nuvalent Inc | 2,705 | 298.6K $ | 0.41 % |
| 39 | Halozyme Therapeutics Inc | 4,364 | 290.4K $ | 0.39 % |
| 40 | IMMUNITYBIO INC | 38,008 | 285.8K $ | 0.39 % |
| 41 | VAXCYTE INC | 5,321 | 273.5K $ | 0.37 % |
| 42 | Alkermes PLC | 6,163 | 260K $ | 0.35 % |
| 43 | IMMUNOVANT INC | 7,523 | 250.5K $ | 0.34 % |
| 44 | KYMERA THERAPEUTICS INC | 3,017 | 245.6K $ | 0.33 % |
| 45 | Protagonist Therapeutics Inc | 2,361 | 235.1K $ | 0.32 % |
| 46 | MIRUM PHARMACEUTICALS INC | 2,231 | 226.4K $ | 0.31 % |
| 47 | PTC Therapeutics Inc | 3,062 | 226.1K $ | 0.31 % |
| 48 | Rhythm Pharmaceuticals Inc | 2,526 | 223.1K $ | 0.30 % |
| 49 | Spyre Therapeutics Inc | 2,905 | 213.5K $ | 0.29 % |
| 50 | COGENT BIOSCIENCES INC | 6,002 | 209.8K $ | 0.28 % |
| 51 | CRISPR Therapeutics AG | 3,550 | 199.4K $ | 0.27 % |
| 52 | CG ONCOLOGY INC | 3,123 | 194.5K $ | 0.26 % |
| 53 | Scholar Rock Holding Corp | 3,773 | 186K $ | 0.25 % |
| 54 | Centessa Pharmaceuticals PLC | 4,423 | 175.9K $ | 0.24 % |
| 55 | CARIS LIFE SCIENCES INC | 10,431 | 174.4K $ | 0.24 % |
| 56 | Ligand Pharmaceuticals Inc | 736 | 170.7K $ | 0.23 % |
| 57 | Xenon Pharmaceuticals Inc | 3,074 | 168.2K $ | 0.23 % |
| 58 | Apogee Therapeutics Inc | 2,028 | 166.6K $ | 0.23 % |
| 59 | Indivior Pharmaceuticals Inc | 4,624 | 166.6K $ | 0.23 % |
| 60 | TRAVERE THERAPEUTICS INC | 3,409 | 160.8K $ | 0.22 % |
| 61 | Amneal Pharmaceuticals Inc | 11,632 | 153.2K $ | 0.21 % |
| 62 | TWIST BIOSCIENCE CORP | 2,266 | 151.5K $ | 0.21 % |
| 63 | Erasca Inc | 11,444 | 146.9K $ | 0.20 % |
| 64 | NEWAMSTERDAM PHARMA COMPANY NV | 4,252 | 143.2K $ | 0.19 % |
| 65 | Crinetics Pharmaceuticals Inc | 3,872 | 137.6K $ | 0.19 % |
| 66 | ACADIA Pharmaceuticals Inc | 6,303 | 136.5K $ | 0.19 % |
| 67 | Veracyte Inc | 2,938 | 136.1K $ | 0.18 % |
| 68 | Edgewise Therapeutics Inc | 3,966 | 135.5K $ | 0.18 % |
| 69 | Beam Therapeutics Inc | 3,767 | 124K $ | 0.17 % |
| 70 | Denali Therapeutics Inc | 5,863 | 123.4K $ | 0.17 % |
| 71 | 10X Genomics Inc | 4,351 | 123.2K $ | 0.17 % |
| 72 | DYNE THERAPEUTICS INC | 6,087 | 117.7K $ | 0.16 % |
| 73 | STRUCTURE THERAPEUTICS INC | 2,880 | 113.3K $ | 0.15 % |
| 74 | Tango Therapeutics Inc | 4,978 | 109.4K $ | 0.15 % |
| 75 | ORUKA THERAPEUTICS INC | 1,789 | 104.7K $ | 0.14 % |
| 76 | GRAIL Inc | 1,439 | 103.1K $ | 0.14 % |
| 77 | ALUMIS INC | 4,674 | 101K $ | 0.14 % |
| 78 | Arcutis Biotherapeutics Inc | 4,587 | 98.4K $ | 0.13 % |
| 79 | Disc Medicine Inc | 1,411 | 98.2K $ | 0.13 % |
| 80 | Supernus Pharmaceuticals Inc | 2,120 | 97.9K $ | 0.13 % |
| 81 | Ideaya Biosciences Inc | 3,246 | 95.7K $ | 0.13 % |
| 82 | VERA THERAPEUTICS INC | 2,636 | 93.6K $ | 0.13 % |
| 83 | TARSUS PHARMACEUTICALS INC | 1,573 | 93.4K $ | 0.13 % |
| 84 | Relay Therapeutics Inc | 6,606 | 92.8K $ | 0.13 % |
| 85 | Mineralys Therapeutics Inc | 2,925 | 92.1K $ | 0.13 % |
| 86 | Definium Therapeutics Inc | 3,685 | 89.1K $ | 0.12 % |
| 87 | Enliven Therapeutics Inc | 2,196 | 86.9K $ | 0.12 % |
| 88 | Adaptive Biotechnologies Corp | 5,692 | 86.2K $ | 0.12 % |
| 89 | Ultragenyx Pharmaceutical Inc | 3,571 | 85.5K $ | 0.12 % |
| 90 | LEGEND BIOTECH CORP | 3,122 | 84.8K $ | 0.12 % |
| 91 | Kodiak Sciences Inc | 2,255 | 82.8K $ | 0.11 % |
| 92 | BioCryst Pharmaceuticals Inc | 9,271 | 82.6K $ | 0.11 % |
| 93 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 1,698 | 82.1K $ | 0.11 % |
| 94 | Aurinia Pharmaceuticals Inc | 4,914 | 75.3K $ | 0.10 % |
| 95 | OCULAR THERAPEUTIX INC | 8,049 | 72.5K $ | 0.10 % |
| 96 | Novocure Ltd | 4,209 | 71.7K $ | 0.10 % |
| 97 | Pharvaris NV | 2,367 | 71.4K $ | 0.10 % |
| 98 | Sionna Therapeutics Inc | 1,651 | 70.7K $ | 0.10 % |
| 99 | ADMA Biologics Inc | 8,805 | 70.3K $ | 0.10 % |
| 100 | Rapport Therapeutics Inc | 1,764 | 69.7K $ | 0.09 % |
Sector breakdown
- Health care 46.5 %
- Unattributed 53.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.7 %
- Netherlands 2.5 %
- Ireland 1.9 %
- Bermuda 1.7 %
- France 1.5 %
- Denmark 1.2 %
- Germany 0.9 %
- Canada 0.7 %
- United Kingdom 0.5 %
- Switzerland 0.5 %
- Cayman Islands 0.3 %
- Jersey 0.2 %
- Other countries 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 216 | 40.7M $ | 87.65 % |
| 2 | Netherlands | 4 | 1.2M $ | 2.49 % |
| 3 | Ireland | 4 | 873.3K $ | 1.88 % |
| 4 | Bermuda | 1 | 793.5K $ | 1.71 % |
| 5 | France | 2 | 696.3K $ | 1.50 % |
| 6 | Denmark | 2 | 572.7K $ | 1.23 % |
| 7 | Germany | 1 | 404.2K $ | 0.87 % |
| 8 | Canada | 3 | 312.7K $ | 0.67 % |
| 9 | United Kingdom | 5 | 255.3K $ | 0.55 % |
| 10 | Switzerland | 2 | 209.3K $ | 0.45 % |
| 11 | Cayman Islands | 5 | 152.6K $ | 0.33 % |
| 12 | Jersey | 1 | 71.7K $ | 0.15 % |
Cite this page
Titelia. "Holdings of ProShares Ultra Nasdaq Biotechnology". https://titelia.com/en/funds/S000018718